Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment

Xiaodi Li,Ling Xu,Lianfeng Lu,Xiaosheng Liu,Yang Yang,Yuanni Wu,Ting Zhu,Xiaoxia Li,Yanling Li,Xiaojing Song,Yang Han,Wei Lyu,Wei Cao,Taisheng Li
DOI: https://doi.org/10.1186/s12967-024-05681-y
IF: 8.44
2024-10-06
Journal of Translational Medicine
Abstract:Several studies have reported that combination antiretroviral therapy (cART) enhances the hepatitis B surface antigen (HBsAg) clearance rate in Human Immunodeficiency Virus-1/Hepatitis B Virus (HIV/HBV) coinfected patients, yet the associated immunological characteristics remain unclear.
medicine, research & experimental
What problem does this paper attempt to address?